Ledger.Open graph →
SEC Form D · Amendment · filed March 6, 2026

EnZeta Immunotherapies, Inc

Offering
$2.4M
Sold
$840K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CORAL GABLES, FL
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (2)

Paul Kelly · BOULDER, COExec · DirectorSergio Traversa · New York, NYDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗